Columbia Financial insider files sale of 33,519 shares; 83,294 options vested
Rhea-AI Filing Summary
Noel R. Holland, a director of Columbia Financial, Inc. (CLBK), reported changes in beneficial ownership dated 10/03/2025. The filing shows an acquisition of 11.1873 stock units purchased through a rabbi trust under the stock-based deferral plan at a price of $14.89. The report also shows a disposition of 33,519 common shares and continued indirect holdings of 46,280 shares in a SEP-IRA plus 3,207 shares held via a stock award that vests on 03/11/2026. The reporting person holds 83,294 exercisable stock options with an exercise price of $15.60 expiring on 07/23/2029.
The filing includes explanations that the acquired units are phantom stock under the Columbia Bank Stock Based Deferral Plan and will be settled in shares on distribution; the stock awards vest in one year and the noted options are fully vested and exercisable.
Positive
- Acquired 11.1873 phantom stock units via the Stock Based Deferral Plan at $14.89
- 83,294 stock options are fully vested and exercisable, providing potential alignment with shareholder value
Negative
- Disposition of 33,519 common shares was reported on 10/03/2025, reducing direct/indirect holdings
- Significant option exposure (83,294 options) concentrates potential voting/ownership shifts if exercised
Insights
Director adjusted holdings via plan-driven purchase and a notable disposition.
The report records a small plan-driven acquisition of 11.1873 phantom stock units at $14.89 alongside a reported sale of 33,519 shares. The acquisition is described as non-discretionary through a trustee-held rabbi trust, indicating it resulted from a deferral plan rather than an open-market purchase.
Because the acquisition is plan-based and the options are fully vested (07/23/2029 expiration), the change primarily reflects routine compensation and portfolio rebalancing. Monitor vesting on 03/11/2026 and any future open-market trading disclosures for additional governance signal within the next 6–12 months.
Equity awards and exercises show standard use of long-term incentives and deferred compensation.
Stock units were acquired under the Stock Based Deferral Plan and stock awards are scheduled to vest on 03/11/2026. The filing discloses 83,294 vested/options exercisable at $15.60, with an expiration of 07/23/2029, indicating significant in-the-money optionality depending on market price.
These holdings tie executive/board pay to equity performance; the critical near-term items are the 03/11/2026 vesting and any exercise or sale activity tied to the 83,294 options over the option life through 07/23/2029.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 11.187 | $14.89 | $166.58 |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 11, 2026. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
